Cash Advance Texas Cash Advance Texas

THE LATEST WORD

Top Industry Stories- March 31, 2010

Posted on March 31st, 2010 | by Rxmedyn | No Comments »

Glaxo, Isis In Drug Development Deal Of Up To $1.5 Billion

Astellas Extends Tender Offer For OSI To April 23

Eisai Seeks Approval for Breast Cancer Drug Globally

FDA Accepts Glenmark’s Review Plea For Painkiller

The Last Piece in Place

Read the rest of this entry »

Top Industry Stories- March 30, 2010

Posted on March 30th, 2010 | by Rxmedyn | No Comments »

Waiting Period Ends For Rigel-AstraZeneca Licensing Agreement Announced Last Month

Update 1- Eli Lilly Says To Launch 15 New Products In China

Stada Sees Chance for Growth In 2010 Earnings, Sales (Update 2)

Regulators Reject a Drug Maker’s Plan To Use Its Alertness Pill To Overcome Jet Lag

Sanofi, Bristol Reap Two Victories on Plavix

Read the rest of this entry »

Top Industry Stories – March 29, 2010

Posted on March 29th, 2010 | by Rxmedyn | No Comments »

Test Predicts Which Patient Benefit From $6Billion MS Drugs

F.D.A. Says Millions Got Unapproved Heart Pills

Obama to Nominate Berwick for Medicare-Medicaid Post

Healthcare Overhaul Q & A How the New Health Law Could Affect You, and How Soon

For Many, MS drugs Not Helpful, Study Shows

Read the rest of this entry »

Top Industry Stories – March 26, 2010

Posted on March 26th, 2010 | by Rxmedyn | No Comments »

More Doctors Giving Up Private Practices

Pfizer Loses Lipitor Patent Suits in South Korea, Court Says

CVS Caremark Task Force Probe Includes Connecticut, Illinois

Merkel Breaks Drugmaker Hold on Prices With Cost-Cutting Plan

Focus Less On Price, More On Value, Says Lilly Chief

Read the rest of this entry »

Top Industry Stories – March 25, 2010

Posted on March 25th, 2010 | by Rxmedyn | No Comments »

G.O.P. Forces New House Vote on Fixes to Health Bill

Democrats Promote Overhaul’s Benefits to Older Americans

Coburn’s Erectile Dysfunction Amendment is Killed

Social Networks a Lifeline for the Chronically Ill

Health Law Surprise Is Page 1,617 Demanding Which Drugs Work

Read the rest of this entry »

Top Industry Stories – March 24, 2010

Posted on March 24th, 2010 | by Rxmedyn | No Comments »

Deal Provides Vaccines to Poor Nations at Low Cost

Health Care Suits by States ‘Unlikely to Succeed,’ Scholars Say

U.S. Medicare To Pay For “Fillers” in HIV Patients

Breast Cancer Screening Fails to Reduce Deaths in Danish Study

Tanning Tax, Family Insurance to Take Effect in 2010

Read the rest of this entry »

Top Industry Stories – March 23, 2010

Posted on March 23rd, 2010 | by Rxmedyn | No Comments »

Health Vote is Done, But Partisan Debate Rages On

Health Measure’s Opponents Plan Legal Challenges

Republicans Dealt Blow on Health Care by US Senate Official

Merck Suspends Stimuvax Studies on Side Effect

GW Pharmaceuticals Reports Data From Sativex Phase IIB Trial

Read the rest of this entry »

Top Industry Stories – March 22, 2010

Posted on March 22nd, 2010 | by Rxmedyn | No Comments »

In Health Care Reform, Boons for Hospitals and Drug Makers

PhRMA Statement on Health Care Reform

Sanofi’s Multaq Tests Indicate Low Price in France, Tribune Says

Drug Trials Have Excluded Gays

US Senate Panel Commence Drug Pricing Probe

Read the rest of this entry »

Tip Industry Stories – March, 19, 2010

Posted on March 19th, 2010 | by Rxmedyn | No Comments »

A Company Races to Keep a Drug Patent

Ratiopharm Gives Teva ‘Last Ticket’ to German Generics Market

Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says

Pfizer Drops Viagra Infringement Case Against Lilly

AstraZeneca Wins First Seroquel Trial, Signs Alzheimer’s Pact

Read the rest of this entry »

Top Industry Stories – March 18, 2010

Posted on March 18th, 2010 | by Rxmedyn | No Comments »